Researchers developed a “clock” model that based on a single blood test can estimate Alzheimer’s symptom onset in cognitively unimpaired adults.

The model predicted onset age with a roughly 3-year median margin of error.

— Findings could streamline enrollment for Alzheimer’s clinical trials.